A purple and pink letter v on a white background.
June 13, 2019

Webinar Recording: Optimal Hair Restoration Outcomes with NeoGraft®

The hair restoration market has seen a phenomenal boost in recent years, with an increase of over 500% in the number of hair transplant procedures performed from 2012 to 2017, according to a survey by the American Academy of Facial Plastic and Reconstructive Surgery (AAFPRS). What’s more, the American Hair Loss Association reports that over 65% of American men experience appreciable hair loss by the age of 35, with that number jumping to 85% by the age of 50. Considering these numbers, now is the perfect timing to capitalize on this opportunity by adding hair restoration to your practice.

To help set you on the right path, we turned to Board Certified Plastic Surgeon, Dr. Paul M. Glat, and his Business Administrator, Tom Horner. In this webinar, they discuss their experience with the NeoGraft® hair restoration device, how its optimal hair loss solutions provide proven patient results, and how the technology has increased their overall profitability. The duo walks you through how they built a practice around hair restoration and what a NeoGraft® partnership entails. Hair restoration with NeoGraft® now makes up more than half of Dr. Glat’s business, and the procedure is able to yield high profit ratios while helping them even out the gender distribution among his customers to a 50/50 ratio. Watch the full recording below to hear more!

What Is NeoGraft®?

NeoGraft® is an automated Follicular Unit Extraction (FUE) and implantation system, proven to deliver high patient satisfaction, superior clinical efficacy, and significant profit margins for the physician. The procedure is minimally invasive with no linear scarring, allowing patients to enjoy a fuller, natural-looking hairline with fast recovery and minimal impact on their daily life. The new and improved NeoGraft® 2.0 platform now offers an extended and double-jointed arm, updated implant and extraction tools, a pneumatic motor, and a touchscreen interface for a highly optimized workflow and greater efficiency.

What It Means to Partner with NeoGraft® 

There are many perks of being a NeoGraft® partner. Customers will have exclusive access to our VeroGrafters™ program, which allows effortless scheduling of on-demand hair restoration technicians with the ease of an app. You’ll also be able to take advantage of NeoGraft®’s patient lead generation funnel (where area-specific leads are directly referred to NeoGraft® practices), as well as resources such as our mentorship program, marketing support, dedicated practice consulting, and a Loyalty Rewards Program. Discover how NeoGraft® can help your practice achieve similar success by contacting an expert using the button below.

The VeroGrafters™ Program is not available in every jurisdiction where NeoGraft systems are sold.

By Yoni Nowmalki July 28, 2026
TORONTO, July 28, 2026 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”), a global medical aesthetic technology leader, today announced it has entered into an exclusive distribution agreement with HIRONIC Co. Ltd. (“HIRONIC”), a KOSDAQ listed South Korean company specializing in medical aesthetic devices, pursuant to which the Company acquires the exclusive right to distribute HIRONIC’s Doublo 2.0 device in the United States and Canada. The “New Doublo 2.0” is a synergistic, multi-energy-based medical device platform for the face and body, equipped with two separate handpieces that enables clinics to offer customer Cold Plasma and RF microneedling treatments. The device has received 510(k) certification from the U.S. Food and Drug Administration, and the Company intends to make it available to customers in the United States during 2H 2026. Venus Concept will support future regulatory approval efforts in Canada for the device and any additional handpiece technologies for both regions. “HIRONIC is a global leader in developing innovative medical aesthetic technologies and we are excited for the new partnership, starting with the Doublo x Venus Signature Edition,” said Rajiv De Silva, Chief Executive Officer of Venus Concept. “With this device, we look forward to offering our customers an innovative, exclusive Cold Plasma and RF Microneedling platform. By combining these complementary technologies, the platform delivers synergistic effects from the epidermis to the dermis, enabling comprehensive skin rejuvenation by addressing multiple skin concerns and enhancing overall skin revitalization. The Doublo also complements our existing portfolio by enhancing the range of treatment modalities for a customizable treatment plan to address each patient’s skin needs. We aim to expand our partnership in the future to bring to our customers additional new and novel technologies from HIRONIC, once regulatory approvals have been obtained.” About Venus Concept Venus Concept is an innovative global medical aesthetic technology leader with a broad product portfolio of minimally invasive and non-invasive medical aesthetic and hair restoration technologies and reaches over 60 countries and 9 direct markets. Venus Concept's product portfolio consists of aesthetic device platforms, including Venus NOVA, Venus Versa, Venus Versa PRO, Venus Bliss, Venus Bliss MAX, Venus Viva, Venus Viva MD, Venus Legacy, Venus Velocity, Venus Epileve and AI.ME. Venus Concept's hair restoration systems include NeoGraft® and the ARTAS iX® Robotic Hair Restoration system. Venus Concept is backed by Madryn Asset Management, a leading healthcare investment firm that provides capital to innovative growth-stage healthcare companies offering unique and transformative products and technologies. Investor Relations Contact: Damian Yeung, CPA investorrelations@venus.ai View Full Article
May 22, 2026
Skin Cancer Awareness Month highlights prevention and early detection. Learn how dermatologists support care with advanced tools and treatments.
May 22, 2026
Skin cancer radiotherapy improves treatment precision and patient outcomes. Learn how dermatology clinics use it in modern care plans.